Hydrogenology
Hydrogenology editorial study record

An H₂-infused, nitric oxide-producing functional beverage as a neuroprotective agent for TBIs and concussions

LeBaron TW, Kharman J, McCullough ML. · J Integr Neurosci. 2021;20(3):667–676.

HumanOther formsPublished 2021
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Human

Reported design

Open-label exploratory case series

Research topic

Other neurological conditions

Administration classification

Other forms

Study result signal

Indeterminate for molecular hydrogen.

Outcome type

Exploratory neurocognitive and functional measures for a combined product.

Reported in the source

Methods at a glance

Population or model

Six men older than 65 years; the article highlights serial results from one 74-year-old participant.

Sample

6 participants, with detailed graphical follow-up centered on one case.

Duration

Repeated intake and longitudinal testing reported in the article.

Intervention

A beverage containing molecular hydrogen and nitric-oxide-stimulating ingredients.

Hydrogen form

H₂ dissolved in a combined functional beverage.

H₂ specification

More than 2 mg/L dissolved H₂; the product also contained nitric-oxide-producing ingredients.

H₂ flow

Not applicable — oral beverage.

O₂ delivered with H₂

No oxygen was co-delivered.

Comparator

No concurrent control.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Cognitive and sensory testing and functional observations.

Reported result

The article describes favorable changes on selected tests, with much of the longitudinal presentation based on one participant.

Results-extraction completeness

The full article methods, intervention, outcomes, positive and null findings, funding and conflict statements were checked.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Open-label, uncontrolled, extremely small and inseparable from nitric-oxide-producing ingredients; commercial and product-development conflicts are relevant.

Applies directly to

The combined beverage and tested participants only.

Preliminary appraisal framework

JBI case-report or case-series checklist — preliminary

Preliminary risk-of-bias status

Critical risk

Appraisal rationale

Critical confounding, selective case emphasis, no control and direct product-related conflicts.

Appraisal domains

Selection and allocation checked · Confounding and co-interventions remain possible · Missing observations checked where reported · Outcome measurement varies by endpoint · Selective reporting cannot be excluded

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 34645100 · DOI: 10.31083/j.jin2003071

Publisher access

A free publisher or repository full article was checked.

Extraction basis

Publisher or repository full article and bibliographic record; checked 10 August 2026.

Record revision

2026-08-10